Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.12
+0.73 (5.89%)
At close: May 12, 2025, 4:00 PM
13.04
-0.08 (-0.61%)
After-hours: May 12, 2025, 4:02 PM EDT
Viridian Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$36.82
Upside
+180.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $46 → $45 | Buy | Maintains | $46 → $45 | +242.99% | May 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $31 → $27 | Strong Buy | Maintains | $31 → $27 | +105.79% | May 7, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $42 → $38 | Buy | Maintains | $42 → $38 | +189.63% | May 7, 2025 |
| Needham | Needham | Strong Buy Maintains $38 → $36 | Strong Buy | Maintains | $38 → $36 | +174.39% | May 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +159.15% | Apr 23, 2025 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +189.63% | Jan 7, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $27 | Buy → Hold | Downgrades | $27 | +105.79% | Dec 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $44 → $47 | Buy | Maintains | $44 → $47 | +258.23% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +159.15% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +159.15% | Dec 16, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $44 | Buy | Reiterates | $44 | +235.37% | Dec 5, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +189.63% | Nov 25, 2024 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $34 | Strong Buy | Maintains | $27 → $34 | +159.15% | Nov 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +189.63% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +189.63% | Oct 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.